1Lee SR,Kim SP,Kim JE.Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils[J].Neurosc Letter,2000,281(2-3):183-186.
2Edmonds HL Jr,Jiang YD,Zhang PY,et al.Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration[J].Life Sci,2001,69(19):2265-2277.
9Khan SH,Wright SL,Banigesh A,et al.Antiischemic effects of topiramate in a transient global forebrain ischemia model:Neurochemical,histological,and behavioral evaluation[J].Neurochem Res,2003,28(8):1235-1239.
10Smith-Swintosky VL,Zhao B,Shank RP,et al.Topiramate promotes neurite outgrowth and recovery of function after nerve injury[J].Neuroreport,2001,12(5):1031-1034.
5Johannessen SI. Pharmacokmetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs.Epileosia, 1997, 38(Suppl 1): S18 -S23.
6Doose DR, Walker SA, Gisclon LG, et al. Single-dose pharmacokinetics and effect of food on the bioavailability of topkamate, a novel antiepileptic drug. J Clin Pharmacol, 1996, 36:884-891.
7Reife RA. Topiramate. In: Shorvon S, Dreifuss F, Fish D, Thomas D, eds. The Treatment of Epilepsy. Oxford: Blackwell Science Ltd,1996.471 -481.
8Christensen J, Hojskov CS, Dam M, et al. Plasma concentration of topiramate correlates with cerebrospinal fluid concentration. Ther Drug Monit, 2001, 23 : 529 - 535.
9Lindberger M, Tomson T, Ohman I, et al. Estimation of topiramate in subdural cerebrospinal fluid, subcutaneous extracellalar fluid, and plasma: a single case microdialysis study. Epilepsia, 1999, 40:800 -802.
10Yang Y, Shuaib A, Li Q, et al. Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization. Brain Res, 1998, 804:169 - 176.
10Drapalski A L,Rosse R B,Peebles R R,et al. Topiramate improves deficit symptoms in a patient with schizophrenia when added to a stable regimen of antipsyehotie medication [J]. Clin Neuropharma- col, 2001,24: 290-294.
